IRLAB Q4 - Upcoming Pirepemat readout in focus
2025-02-14 09:45:00
Redeye returns following IRLAB's Q4 report and recent news in the company. We note that 2025 will be an important year for the company - with an important readout in Pirepemat already now in Q1.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/